Global Infertility Treatment Market, By Sex (Males, Females and Unexplained), Diagnosis (Men Diagnostic Tests, Women Diagnostic and General Diagnostic Tests), Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment and Others), Techniques (Assisted Reproductive Technology (ART), Intrauterine Insemination, and Surgery) – Industry Trends and Forecast to 2029
Global Infertility Treatment Market Analysis and Size
Infertility is a prevailing issue all around the globe. According to a recent report, 25% of the women with fertility issue suffer irregular ovulation. Smoking populations has shown symptoms of decreased fertility. All of this has induced funds towards research and development activities to understand the reasons and develop drugs for the treatment.
- Data Bridge Market Research analyses that the infertility treatment market is expected to undergo a CAGR of 8.03% during the forecast period. This indicates that the market value, which was USD 1.50 billion in 2021, would rocket up to USD 2.78 billion by 2029. “Assisted Reproductive Technology (ART)” dominates the application segment of the infertility treatment market owing to the increasing number of technological advancements, growing awareness about assisted reproductive technology (ART) and increase in funding for research and development into microbiome-based therapies worldwide. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Infertility Treatment Market Definition
From the name itself, it is clear that infertility treatment is the treatment options available to treat an individual suffering from infertility. Infertility is a medical condition of an individual’s inability to reproduce owing to the dearth of fertile semen. Infertility occurs due to various reasons, however, this doesn’t mean that it cannot be treated or there are any dearth of alternatives.
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
Sex (Males, Females and Unexplained), Diagnosis (Men Diagnostic Tests, Women Diagnostic and General Diagnostic Tests), Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment and Others), Techniques (Assisted Reproductive Technology (ART), Intrauterine Insemination, and Surgery)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
The Cooper Companies Inc. (US), Cook (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), Carl Zeiss AG (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US)
Infertility Treatment Market Dynamics
- The rise in the level of smoking
Surging consumption of smoking products is directly influencing the market demand and supply. It is scientifically proven that the consumption of tobacco and tobacco related products affect the fertility level in both men and women.
- Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the development of drugs and novel treatment options is also bolstering the market growth rate.
- Government investments on healthcare infrastructure
The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Also, high return on investments assured by the research activities will also work in the favour of the market.
Additionally, surge in incidences of lifestyle diseases, genetic abnormalities, stress, obesity, prostate cancer, varicocele and others, surge in the personal disposable income level, rising number of fertility clinics worldwide, increasing investment for the development of advanced medical products and devices and emerging markets such as China, India, Brazil, and Mexico , positively affect the market growth rate.
Furthermore, upsurge in the public-private funding for target research activities, growing geriatric population base and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising internet penetration rate, growing number of hospitals and laboratories, growing awareness about in-vitro fertilization and its benefits and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/Challenges Global Infertility Treatment Market
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and growing complexities and concerns related to assisted reproductive technology (ART) are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, high costs associated with assisted reproductive technology (ART) procedures, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
This infertility treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the infertility treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Infertility Treatment Market
COVID-19 has had a negative impact on the market. Focus drawn away from non-essential healthcare services to meeting the demands of COVID-19 patients derailed the market growth rate. Instructions were laid down towards protecting public and hospital frontline workers from exposure to the COVID-19 infection. During this pandemic phase, a 90% drop was observed in the number of people undergoing in-vitro fertilization cycles owing to the cancellation of in-vitro fertilization treatments. All of this led to hampering the market growth rate.
- In 2021, CooperSurgical announced a partnership with Virtus Health to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples.
- In 2021, Hamilton Thorne Ltd. received FDA approval for the commercialization of the GYNEMED GM501, a ready-to-use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe.
- In 2020, Genea Biomedx (Australia) collaborated with Hamilton Thorne to commercialize Genea Biomedx’s (Australia) fertility products in the US and Canada.
Global Infertility Treatment Market Scope
The infertility treatment market is segmented on the basis of sex, diagnosis, drugs and techniques. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Based on the sex, the infertility treatment market is segmented into males, females and unexplained.
- Men Diagnostic Tests
- Women Diagnostic
- General Diagnostic Tests
Based on the diagnosis, the infertility treatment market is segmented into men diagnostic tests, women diagnostic tests, and general diagnostic tests. Men diagnostic tests is further sub segmented into semen analysis, genetic testing, testicular biopsy, and other. Women diagnostic tests is further sub segmented into hysteroscopy, laparoscopy, ovulation testing, hysterosalpingography and others. General diagnostic tests is further sub segmented into genetic testing, hormone testing, microscopic analysis, imaging, and others.
- Clomiphene Citrate
- Hormone Treatment
Based on the drugs, the infertility treatment market is segmented into clomiphene citrate, letrozole, serophene, hormone treatment and others.
- Assisted Reproductive Technology (ART)
- Intrauterine Insemination
Based on the techniques, the infertility treatment market is segmented into assisted reproductive technology (ART), intrauterine insemination, and surgery. Surgery is further sub segmented into laparoscopic or hysteroscopic surgery, tubal surgeries and others.
Infertility Treatment Market Regional Analysis/Insights
The infertility treatment market is analysed and market size insights and trends are provided by country, sex, diagnosis, drugs and techniques as referenced above.
The countries covered in the infertility treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infertility treatment market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, good repayment schemes by the governmental bodies, growing number of processes pertaining to drug development, and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, rise in the incidences of lifestyle-related diseases, growing demand for smoking products and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The infertility treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infertility treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infertility treatment market. The data is available for historic period 2010-2020.
Competitive Landscape and Infertility Treatment Market Share Analysis
The infertility treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to infertility treatment market.
Some of the major players operating in the infertility treatment market are The Cooper Companies Inc. (US), Cook (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), Carl Zeiss AG (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US) among others.
Research Methodology : Global Infertility Treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-infertility-treatment-market